Requiring coverage of pharmacogenomic testing for psychotropic medications.
Sponsored By: Lauren Davis (Democratic)
Failed
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & Cosponsors
Sponsor
Lauren Davis
Democratic • House
Cosponsors
Alicia Rule
Democratic • House
Beth Doglio
Democratic • House
Edwin Obras
Democratic • House
Lisa Parshley
Democratic • House
Liz Berry
Democratic • House
Mia Gregerson
Democratic • House
Monica Jurado Stonier
Democratic • House
Nicole Macri
Democratic • House
Steve Tharinger
Democratic • House
Tarra Simmons
Democratic • House
Timm Ormsby
Democratic • House
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
By resolution, reintroduced and retained in present status.
1/12/2026HouseFirst reading, referred to Health Care & Wellness.
1/20/2025House
Bill Text
Original Bill
1/20/2025
Related Bills
HB 1960, Encouraging renewable energy in Washington through tax policy and investment in local communities.
HB 2034, Concerning termination and restatement of plan 1 of the law enforcement officers' and firefighters' retirement system.
HB 2681, Modifying cannabis producer, processor, and retailer license fees.
HB 2689, Concerning the working connections child care program.
SB 6228, Removing a tax exemption for the warehousing and reselling of prescription drugs.
HB 2487, Concerning taxes imposed on insurers operating within the state.